文献速递湿疹皮炎与荨麻疹

患者报告结局测量睡眠障碍在儿童特应性皮炎中的应用:PROMIS儿科睡眠量表与活动记录仪的横断面研究

Patient-reported outcomes for measuring sleep disturbance in pediatric atopic dermatitis: Cross-sectional study of the Patient Reported Outcomes Measurement Information System pediatric sleep measures and actigraphy.
PubMed 文献 · J Am Acad Dermatol · 2020-06-03

本研究在61例5至17岁特应性皮炎(AD)患儿中测试PROMIS睡眠量表,并评估其信度、效度及与疾病严重度、瘙痒和生活质量的相关性。结果显示PROMIS睡眠障碍家长代理信度高(Cronbach α=0.90),能区分POEM定义的疾病严重度组,且与瘙痒、睡眠相关损害及生活质量恶化相关。基于POEM睡眠问题的高敏感性,提出筛查与干预算法,建议用POEM睡眠问题初筛,必要时用PROMIS或客观监测进一步评估。

要点

  • PROMIS睡眠障碍家长代理量表在儿童AD中信度高(Cronbach α=0.90)。
  • PROMIS睡眠障碍评分可区分POEM定义的轻、中、重度AD组。
  • POEM睡眠问题阳性对PROMIS家长代理睡眠障碍(T≥60)敏感性高(95%)。

核心结论

  • 儿童AD睡眠障碍应使用POEM睡眠问题筛查,必要时用PROMIS睡眠障碍量表或客观睡眠监测进一步评估。

研究设计与样本

  • 横断面研究纳入61例5至17岁AD患儿及1名家长,完成睡眠、瘙痒及AD相关问卷,临床医生评估疾病严重度,所有儿童佩戴活动记录仪1周进行客观睡眠评估。

主要发现

  • PROMIS睡眠障碍家长代理信度高(Cronbach α=0.90),且能区分POEM定义的疾病严重度组(轻度 vs 中度 vs 重度均值±标准差为55.7±7.5 vs 59.8±10.8 vs 67.1±9.5;P<.01)。
  • 睡眠障碍与瘙痒(数字评定量表,r=0.48)、PROMIS睡眠相关损害(r=0.57)及生活质量恶化(儿童皮肤病生活质量指数,r=0.58)相关,所有P值均<.01。
  • POEM睡眠问题阳性对PROMIS家长代理报告的睡眠障碍(T评分≥60)具有高敏感性(95%)。

关键数值与推荐

  • PROMIS睡眠障碍家长代理信度Cronbach α=0.90。
  • PROMIS睡眠障碍评分在POEM轻度、中度、重度组分别为55.7±7.5、59.8±10.8、67.1±9.5(P<.01)。
  • 睡眠障碍与瘙痒r=0.48、与PROMIS睡眠相关损害r=0.57、与CDLQI r=0.58,均P<.01。
  • POEM睡眠问题阳性对PROMIS家长代理睡眠障碍(T≥60)敏感性95%。

临床怎么用

  • 临床可用POEM睡眠问题初筛儿童AD睡眠障碍,阳性者进一步用PROMIS睡眠障碍量表或客观睡眠监测评估。
  • 研究提出了一套筛查、评估和干预以减少睡眠障碍的算法。

局限性

  • 本研究为局部样本。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Most children with atopic dermatitis (AD) experience sleep disturbance, but reliable and valid assessment tools are lacking. OBJECTIVES: To test the Patient-Reported Outcomes Measurement Information System (PROMIS) sleep measures in pediatric AD and to develop an algorithm to screen, assess, and intervene to reduce sleep disturbance. METHODS: A cross-sectional study was conducted with children with AD ages 5 to 17 years and 1 parent (n = 61), who completed sleep, itch, and AD-specific questionnaires; clinicians assessed disease severity. All children wore actigraphy watches for a 1-week objective sleep assessment. RESULTS: PROMIS sleep disturbance parent proxy reliability was high (Cronbach α = 0.90) and was differentiated among Patient-Oriented Eczema Measure (POEM)-determined disease severity groups (mean ± standard deviation in mild vs moderate vs severe was 55.7 ± 7.5 vs 59.8 ± 10.8 vs 67.1 ± 9.5; P < .01). Sleep disturbance correlated with itch (numeric rating scale, r = 0.48), PROMIS sleep-related impairment (r = 0.57), and worsened quality of life (Children's Dermatology Life Quality Index, r = 0.58), with all P values less than .01. Positive report on the POEM sleep disturbance question has high sensitivity (95%) for PROMIS parent proxy-reported sleep disturbance (T-score ≥ 60). An algorithm for screening and intervening on sleep disturbance was proposed. LIMITATIONS: This was a local sample. CONCLUSIONS: Sleep disturbance in pediatric AD should be screened using the POEM sleep question, with further assessment using the PROMIS sleep disturbance measure or objective sleep monitoring if needed.

来源:J Am Acad Dermatol,查看原文。版权归原作者所有。

引用

  1. Fishbein AB, Lor J, Penedo FJ, et al. Patient-reported outcomes for measuring sleep disturbance in pediatric atopic dermatitis: Cross-sectional study of the Patient Reported Outcomes Measurement Information System pediatric sleep measures and actigraphy. J Am Acad Dermatol. 2020. PMID: 32504726. doi:10.1016/j.jaad.2020.05.138

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。